Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Another Class I Recall For Philips BiPAP Machines

Executive Summary

The US FDA has labelled as class I an August recall of Philips Respironics BiPAP machines due to the potential of hazardous chemicals being inhaled by the user or shutting down the machines.

You may also be interested in...



Another Headache For Philips As Company Recalls Millions Of Sleeping Masks

The US FDA says a Philips recall of more than 17 million masks worn with some recalled breathing machines raises further safety concerns about other medical devices manufactured by the company.

Philips Cites Plastic Contamination Concerns In Latest Recall Of Sleep Apnea Devices

Philips Respironics has recalled more of its BiPAP machines, this time due to the potential for plastic contaminants to be inhaled or shut down the machine.

Philips In Talks With DOJ Over Breathing Machine Recalls

After being subpoenaed by the US Department of Justice in April, Philips says it is negotiating with the department on a consent decree addressing numerous recalled breathing devices made by Philips Respironics.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145869

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel